Literature DB >> 7996989

Resistance to activated protein C and risk of premature myocardial infarction.

N J Samani, D Lodwick, D Martin, P Kimber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7996989     DOI： 10.1016/s0140-6736(94)90495-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Incidence of factor V Leiden in patients with acute myocardial infarction.

Authors:  M S Gowda; M L Zucker; J L Vacek; W L Carriger; D L Van Laeys; J M Rachel; B D Strope
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

2.  Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease.

Authors:  N Irani-Hakime; H Tamim; G Elias; S Choueiry; R Kreidy; J L Daccache; W Y Almawi
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

3.  Evidence against heterozygous coagulation factor V 1691 G-->A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarction.

Authors:  W Prohaska; H Mannebach; M Schmidt; U Gleichmann; K Kleesiek
Journal:  J Mol Med (Berl)       Date:  1995-10       Impact factor: 4.599

4.  Genetic thrombophilia in patients with retinal vascular occlusion.

Authors:  K Greiner; D Peetz; A Winkgen; W Prellwitz; N Pfeiffer; G Hafner
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

5.  Prevalence of factor V Leiden in a Canadian blood donor population.

Authors:  D H Lee; P A Henderson; M A Blajchman
Journal:  CMAJ       Date:  1996-08-01       Impact factor: 8.262

6.  No Prognostic Importance of Resistance to Activated Protein C in Unstable Coronary Artery Disease Despite Signs of Thrombin Activation.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998       Impact factor: 2.300

7.  Activated protein C: a potential cardioprotective factor against ischemic injury during ischemia/reperfusion.

Authors:  Jingying Wang; Ji Li
Journal:  Am J Transl Res       Date:  2009-07-15       Impact factor: 4.060

8.  Treatment with activated protein C (aPC) is protective during the development of myocardial fibrosis: an angiotensin II infusion model in mice.

Authors:  Mryanda J Sopel; Nicole L Rosin; Alec G Falkenham; Michael Bezuhly; Charles T Esmon; Timothy D G Lee; Robert S Liwski; Jean-Francois Légaré
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

Review 9.  Premature Myocardial Infarction: A Rising Threat.

Authors:  Meral Kayikcioglu; Hasan Selçuk Ozkan; Burcu Yagmur
Journal:  Balkan Med J       Date:  2022-03-14       Impact factor: 2.021
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.